We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

81 hedge funds and large institutions have $895M invested in Orchard Therapeutics plc American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

31% more funds holding

Funds holding: 62 → 81 (+19)

18% more capital invested

Capital invested by funds: $755M → $895M (+$139M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
81
Holders Change
+19
Holders Change %
+30.65%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
29
Increased
26
Reduced
17
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$27.7M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$22.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$17.8M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$14.6M
5
RCM
RA Capital Management
Massachusetts
+$14.2M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$98.9M
2
PI
Putnam Investments
Massachusetts
-$11.8M
3
FCMI
Foresite Capital Management IV
California
-$6.63M
4
PA
Perceptive Advisors
New York
-$6.2M
5
CAM
Cormorant Asset Management
Massachusetts
-$3.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
VEA
51
Virtus ETF Advisers
New York
$459K +$195K +1,600 +92%
Allianz Asset Management
52
Allianz Asset Management
Germany
$411K +$364K +2,993 New
Goldman Sachs
53
Goldman Sachs
New York
$339K +$129K +1,059 +75%
Renaissance Technologies
54
Renaissance Technologies
New York
$326K +$288K +2,370 New
AC
55
Athanor Capital
New York
$314K -$6.08K -50 -2%
Cambridge Investment Research Advisors
56
Cambridge Investment Research Advisors
Iowa
$307K +$271K +2,230 New
Two Sigma Investments
57
Two Sigma Investments
New York
$298K +$264K +2,169 New
Janus Henderson Group
58
Janus Henderson Group
United Kingdom
$213K +$188K +1,549 New
M&T Bank
59
M&T Bank
New York
$211K +$32.1K +264 +21%
D.E. Shaw & Co
60
D.E. Shaw & Co
New York
$200K +$177K +1,458 New
Mitsubishi UFJ Asset Management
61
Mitsubishi UFJ Asset Management
Japan
$187K +$166K +1,365 New
Squarepoint
62
Squarepoint
New York
$159K +$141K +1,158 New
Zurich Cantonal Bank
63
Zurich Cantonal Bank
Switzerland
$156K +$138K +1,135 New
California Public Employees Retirement System
64
California Public Employees Retirement System
California
$153K +$135K +1,110 New
TI
65
Trexquant Investment
Connecticut
$151K +$133K +1,095 New
PNC Financial Services Group
66
PNC Financial Services Group
Pennsylvania
$134K -$5.84K -48 -5%
Legal & General Group
67
Legal & General Group
United Kingdom
$113K +$76K +625 +317%
MWNA
68
Marshall Wace North America
New York
$105K +$93K +765 New
Morgan Stanley
69
Morgan Stanley
New York
$81K -$41.1K -338 -37%
FAM
70
Fred Alger Management
New York
$69K +$60.8K +500 New
ED
71
Exane Derivatives
France
$66.4K – – –
UBS Group
72
UBS Group
Switzerland
$57K -$486 -4 -0.9%
LC
73
Lindbrook Capital
California
$48K +$12.2K +100 +40%
Citigroup
74
Citigroup
New York
$42K +$36.7K +302 New
Barclays
75
Barclays
United Kingdom
$32K -$160K -1,317 -85%
1 2
3
4

ORTX Hedge Fund Activity: Q4 2019 in Review

81 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2019, worth a combined $895M — up 18% from $755M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ORTX positions and 10 closed out — a net gain of 19 holders — while 26 added to existing stakes and 17 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $27.7M. The largest seller was Fidelity Investments, cutting an estimated $98.9M.

  • 81 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2019, up from 62 in Q3 2019.
  • Funds reported $895M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2019, up 18% quarter-over-quarter.
  • 29 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2019 and 10 closed out, a net change of +19 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2019 was Wellington Management Group, an estimated $27.7M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q4 2019 was Fidelity Investments, an estimated $98.9M sold.

Based on aggregated 13F filings for Q4 2019.